Neutral
Protara Therapeutics, Inc. (NASDAQ: TARA) has filed a Form 144, indicating proposed sales of common stock by an affiliate/insider. The filing details ...
Baker Brothers Life Sciences, L.P. has reported multiple sales of common stock in Protara Therapeutics (NASDAQ: TARA) via a Form 144 filing. The filin...
Neutral
Protara Therapeutics focuses on developing therapies for rare and specialty diseases with a lean pipeline centered on oncology and pediatric condition...